Bowling Portfolio Management LLC Enanta Pharmaceuticals Inc Transaction History

Bowling Portfolio Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$81.3 - $97.35 $380,565 - $455,695	-4,681 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$69.08 - $105.66 $1,312 - $2,007	-19 Reduced 0.4%	4,681 $447,000
Q4 2018 Jan 17, 2019	SELL	$65.41 - $84.65 $653,642 - $845,907	-9,993 Reduced 68.01%	4,700 $333,000
Q3 2018 Oct 18, 2018	SELL	$85.46 - $126.37 $723,333 - $1.07 Million	-8,464 Reduced 36.55%	14,693 $1.26 Million
Q2 2018 Aug 06, 2018	BUY	$81.85 - $120.51 $1.9 Million - $2.79 Million	23,157 New	23,157 $2.68 Million

21.2M

10.4K

2.3K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $236M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bowling Portfolio Management LLC with notifications on news.